Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Published on November 15, 2021

Gosselies, Belgium and New York, N.Y. (Nov. 16, 2021)

Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, announced that it has secured more than $60 million in capital through a strategic partnership with Kiniciti, a U.S.-based investment platform focused on strengthening the cell and gene therapy ecosystem worldwide. Kiniciti is backed by Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm investing in healthcare and technology, and Biospring Partners. The transaction gives Kiniciti a control stake in Ncardia to support growth and enhance capabilities spanning discovery to clinical programs to commercial production.

Continue reading on website
Other news

Cricket Health and Cigna: Results from the First Year of our Collaboration

November 10, 2021
Download the Case StudyCigna, Nov. 15, 2021 – Too often, people with kidney disease do not have the support they need to live their best lives possible. In fact, many experience kidney failure without ever knowing they had kidney disease. To help address this health care challenge, we launched a collaboration with Cigna last year to help diagnose kidney disease earlier and provide personalized, hi

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters, A 503B Outsourced Pharmaceutical Compounding Industry Leader, in Partnership with Leading Health Systems

November 15, 2021
The post Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters, A 503B Outsourced Pharmaceutical Compounding Industry Leader, in Partnership with Leading Health Systems appeared first on Leiters.